BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 15111796)

  • 1. Craniofacial abnormalities in a murine knock-out model of mucopolysaccharidosis I H: a computed tomography and anatomic study.
    Graupman P; Pan D; Konair B; Hartung S; McIvor S; Whitley C; Low W; Lam CH
    J Craniofac Surg; 2004 May; 15(3):392-8. PubMed ID: 15111796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orofacial features of Scheie (Hurler-Scheie) syndrome (alpha-L-iduronidase deficiency).
    Keith O; Scully C; Weidmann GM
    Oral Surg Oral Med Oral Pathol; 1990 Jul; 70(1):70-4. PubMed ID: 2115154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of cone-beam computed tomography with a large field of view in Goldenhar syndrome.
    Nardi C; De Falco L; Selvi V; Lorini C; Calistri L; Colagrande S
    Am J Orthod Dentofacial Orthop; 2018 Feb; 153(2):269-277. PubMed ID: 29407505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. alpha-L-iduronidase deficiency and possible Hurler-Scheie genetic compound. Clinical, pathologic, and biochemical findings.
    Winters PR; Harrod MJ; Molenich-Heetred SA; Kirkpatrick J; Rosenberg RN
    Neurology; 1976 Nov; 26(11):1003-7. PubMed ID: 824566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzyme replacement therapy with laronidase (Aldurazyme) for treating mucopolysaccharidosis type I.
    Jameson E; Jones S; Wraith JE
    Cochrane Database Syst Rev; 2013 Sep; (9):CD009354. PubMed ID: 24085657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apparent allelism of the Hurler, Scheie, and Hurler/Scheie syndromes.
    Mueller OT; Shows TB; Opitz JM
    Am J Med Genet; 1984 Jul; 18(3):547-56. PubMed ID: 6433708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The iduronidase-deficient mucopolysaccharidoses: clinical and roentgenorgraphic features.
    Stevenson RE; Howell RR; McKusick VA; Suskind R; Hanson JW; Elliott DE; Neufeld EF
    Pediatrics; 1976 Jan; 57(1):111-22. PubMed ID: 813180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphologic evaluation and classification of facial asymmetry using 3-dimensional computed tomography.
    Baek C; Paeng JY; Lee JS; Hong J
    J Oral Maxillofac Surg; 2012 May; 70(5):1161-9. PubMed ID: 21763045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sinus complications in mucopolysaccharidosis IH/S (Hurler-Scheie syndrome).
    MacArthur CJ; Gliklich R; McGill TJ; Perez-Atayde A
    Int J Pediatr Otorhinolaryngol; 1993 Feb; 26(1):79-87. PubMed ID: 8444549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucopolysaccharidosis type I Hurler-Scheie syndrome: a case report.
    Lamichhane S; Sapkota A; Sapkota S; Adhikari N; Aryal S; Adhikari P
    Ann Med Surg (Lond); 2024 Jan; 86(1):588-593. PubMed ID: 38222696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucopolysaccharidosis type I.
    Wraith JE; Jones S
    Pediatr Endocrinol Rev; 2014 Sep; 12 Suppl 1():102-6. PubMed ID: 25345091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hybridization studies of fibroblasts from Hurler, Scheie, and Hurler/Scheie compound patients: support for the hypothesis of allelic mutants.
    Fortuin JJ; Kleijer WJ
    Hum Genet; 1980 Feb; 53(2):155-9. PubMed ID: 6766899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiological findings in patients with mucopolysaccharidosis I H/S (Hurler-Scheie syndrome).
    Schmidt H; Ullrich K; von Lengerke HJ; Kleine M; Brämswig J
    Pediatr Radiol; 1987; 17(5):409-14. PubMed ID: 3114705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Four novel mutations underlying mild or intermediate forms of alpha-L-iduronidase deficiency (MPS IS and MPS IH/S).
    Tieu PT; Bach G; Matynia A; Hwang M; Neufeld EF
    Hum Mutat; 1995; 6(1):55-9. PubMed ID: 7550232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Which craniofacial fractures are associated with external auditory canal bleeding?
    Lu C; He D; Yang C
    J Oral Maxillofac Surg; 2014 Jan; 72(1):121-6. PubMed ID: 24075233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scheie syndrome: enzyme replacement therapy does not prevent progression of cervical myelopathy due to spinal cord compression.
    Illsinger S; Lücke T; Hartmann H; Mengel E; Müller-Forell W; Donnerstag F; Das AM
    J Inherit Metab Dis; 2009 Dec; 32 Suppl 1():S321-5. PubMed ID: 19894140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mucopolysaccharidosis I, Hurler syndrome: a case report].
    Amorín M; Carlin A; Prötzel A
    Arch Argent Pediatr; 2012 Oct; 110(5):e103-6. PubMed ID: 23070190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hurler-Scheie syndrome in Niger: a case series.
    Assadeck H; Toudou Daouda M; Bako H; Hassane Djibo F
    J Med Case Rep; 2019 Apr; 13(1):102. PubMed ID: 31018863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome after three years of laronidase enzyme replacement therapy in a patient with Hurler syndrome.
    Thomas JA; Jacobs S; Kierstein J; Van Hove J
    J Inherit Metab Dis; 2006 Dec; 29(6):762. PubMed ID: 17089217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical discrimination of Hurler and Scheie syndromes.
    Hopwood JJ; Muller V
    Clin Sci (Lond); 1979 Sep; 57(3):265-72. PubMed ID: 38945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.